India weighing Russian offer for Sputnik-V vaccine trial, manufacturing

India has received an offer from Russia to conduct a trial and manufacture its “Sputnik-V” COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said.

“The government of India attaches great importance to this offer of partnership from a friend,” said V. K. Paul, member of the Indian federal government think-tank NITI Aayog.

The outcome of discussions on the offer were expected soon, he added. 

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights